Apr 18, 2023 / 04:45PM GMT
Eason Lee - Needham & Co. - Analyst
Good afternoon, everyone. Welcome to our next session here with Amylyx. I'm Eason Lee, one of the associates on the biotech research team here at Needham. And it's my pleasure to be hosting Josh Cohen and Justin Klee, who are the co-CEOs and the co-founders as well as Jim Frates, who is the CFO of the company. We'll start off with a company presentation, followed by some time for Q&A.
Just as a reminder, for the listeners, if you have any questions that you'd like me to ask, please feel free to send it over through the chat function.
And with that, Josh, Justin, let me turn it over to you.
Justin Klee - Amylyx Pharmaceuticals Inc. - Co-CEO & Director
Thanks so much, Jason, for having us today and where we thank everyone for joining us as well. So, Josh and I are the cofounders of Amylyx and very pleased to take you through everything today, along with our colleague, Jim.
So, we're a company focused on neurodegenerative diseases in particular ALS. It really try to keep people living with
Amylyx Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 18, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers